
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9149002
[patent_doc_number] => 20130303525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'KAPPA OPIOID RECEPTOR AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/811020
[patent_app_country] => US
[patent_app_date] => 2011-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33004
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811020
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/811020 | Kappa opioid receptor agonists | Jul 18, 2011 | Issued |
Array
(
[id] => 8612715
[patent_doc_number] => 20130018028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Bi-(indole-2-aceto)-iron II (Ferrous Indole Acetate)'
[patent_app_type] => utility
[patent_app_number] => 13/184502
[patent_app_country] => US
[patent_app_date] => 2011-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4978
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13184502
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/184502 | Bi-(indole-2-aceto)-iron II (Ferrous Indole Acetate) | Jul 15, 2011 | Abandoned |
Array
(
[id] => 8394264
[patent_doc_number] => 20120232105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR INHIBITING OSTEOCLAST GROWTH'
[patent_app_type] => utility
[patent_app_number] => 13/180253
[patent_app_country] => US
[patent_app_date] => 2011-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4228
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13180253
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/180253 | Pharmaceutical composition for inhibiting osteoclast growth | Jul 10, 2011 | Issued |
Array
(
[id] => 8956037
[patent_doc_number] => 08501811
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'TASPASE1 inhibitors and their uses'
[patent_app_type] => utility
[patent_app_number] => 13/162992
[patent_app_country] => US
[patent_app_date] => 2011-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 8881
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162992
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/162992 | TASPASE1 inhibitors and their uses | Jun 16, 2011 | Issued |
Array
(
[id] => 7663719
[patent_doc_number] => 20110312988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'SNS-595 AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/159258
[patent_app_country] => US
[patent_app_date] => 2011-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4002
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312988.pdf
[firstpage_image] =>[orig_patent_app_number] => 13159258
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/159258 | SNS-595 and methods of using the same | Jun 12, 2011 | Issued |
Array
(
[id] => 11793113
[patent_doc_number] => 09402804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Injectable formulations of taxanes for cad treatment'
[patent_app_type] => utility
[patent_app_number] => 13/158610
[patent_app_country] => US
[patent_app_date] => 2011-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 78
[patent_no_of_words] => 63234
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13158610
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/158610 | Injectable formulations of taxanes for cad treatment | Jun 12, 2011 | Issued |
Array
(
[id] => 7652348
[patent_doc_number] => 20110301617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'System and Method for Immobilizing a Tick on a Host'
[patent_app_type] => utility
[patent_app_number] => 13/152792
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10620
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301617.pdf
[firstpage_image] =>[orig_patent_app_number] => 13152792
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/152792 | System and Method for Immobilizing a Tick on a Host | Jun 2, 2011 | Abandoned |
Array
(
[id] => 7650868
[patent_doc_number] => 20110300137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Use of lumefantrine and related compounds in the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/134212
[patent_app_country] => US
[patent_app_date] => 2011-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4339
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300137.pdf
[firstpage_image] =>[orig_patent_app_number] => 13134212
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/134212 | Use of lumefantrine and related compounds in the treatment of cancer | May 31, 2011 | Issued |
Array
(
[id] => 8854261
[patent_doc_number] => 20130143936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => '2-IMINOBIOTIN FORMULATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/700090
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18745
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700090
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/700090 | 2-iminobiotin formulations and uses thereof | May 25, 2011 | Issued |
Array
(
[id] => 8903600
[patent_doc_number] => 20130171103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'METHODS FOR TREATING VIRAL CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/699849
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 38825
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699849
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699849 | METHODS FOR TREATING VIRAL CONDITIONS | May 25, 2011 | Abandoned |
Array
(
[id] => 8916902
[patent_doc_number] => 20130178527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'METHOD FOR PREVENTION OR TREATMENT OF DEGENERATIVE NEUROLOGIAL BRAIN DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/820520
[patent_app_country] => US
[patent_app_date] => 2011-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5141
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820520
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/820520 | Method for prevention or treatment of degenerative neurologial brain disorders | May 17, 2011 | Issued |
| 13/068715 | Treatment and prevention of disorders mediated by la-paf or endothelial cells | May 17, 2011 | Abandoned |
Array
(
[id] => 6090785
[patent_doc_number] => 20110218222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'NEURORESTORATION WITH R(+) PRAMIPEXOLE'
[patent_app_type] => utility
[patent_app_number] => 13/102757
[patent_app_country] => US
[patent_app_date] => 2011-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5700
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218222.pdf
[firstpage_image] =>[orig_patent_app_number] => 13102757
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/102757 | NEURORESTORATION WITH R(+) PRAMIPEXOLE | May 5, 2011 | Abandoned |
Array
(
[id] => 7574155
[patent_doc_number] => 20110269811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/100188
[patent_app_country] => US
[patent_app_date] => 2011-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 84309
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269811.pdf
[firstpage_image] =>[orig_patent_app_number] => 13100188
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/100188 | INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES | May 2, 2011 | Abandoned |
Array
(
[id] => 8745461
[patent_doc_number] => 20130085178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'COMPOSITION FOR TREATING BONE DISEASE COMPRISING A GLYCEOLLIN AS AN ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 13/643597
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 4737
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643597
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/643597 | COMPOSITION FOR TREATING BONE DISEASE COMPRISING A GLYCEOLLIN AS AN ACTIVE INGREDIENT | Apr 27, 2011 | Abandoned |
Array
(
[id] => 7501537
[patent_doc_number] => 20110263524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'SNS-595 AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/095111
[patent_app_country] => US
[patent_app_date] => 2011-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7375
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263524.pdf
[firstpage_image] =>[orig_patent_app_number] => 13095111
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/095111 | SNS-595 AND METHODS OF USING THE SAME | Apr 26, 2011 | Abandoned |
Array
(
[id] => 8749554
[patent_doc_number] => 08415388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-09
[patent_title] => 'Pharmaceutical compositions containing paclitaxel orotate'
[patent_app_type] => utility
[patent_app_number] => 13/066793
[patent_app_country] => US
[patent_app_date] => 2011-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 4395
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13066793
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/066793 | Pharmaceutical compositions containing paclitaxel orotate | Apr 24, 2011 | Issued |
Array
(
[id] => 7817527
[patent_doc_number] => 20120064147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'AGENT FOR IMPROVING TISSUE PENETRATION'
[patent_app_type] => utility
[patent_app_number] => 13/089562
[patent_app_country] => US
[patent_app_date] => 2011-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8903
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064147.pdf
[firstpage_image] =>[orig_patent_app_number] => 13089562
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/089562 | AGENT FOR IMPROVING TISSUE PENETRATION | Apr 18, 2011 | Abandoned |
Array
(
[id] => 8780608
[patent_doc_number] => 20130102583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'CEPHEM COMPOUND HAVING CATECHOL GROUP'
[patent_app_type] => utility
[patent_app_number] => 13/639412
[patent_app_country] => US
[patent_app_date] => 2011-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94141
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639412
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/639412 | Cephem compound having catechol group | Apr 3, 2011 | Issued |
Array
(
[id] => 8968707
[patent_doc_number] => 08507518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'Method of treating mantle cell lymphoma'
[patent_app_type] => utility
[patent_app_number] => 13/078272
[patent_app_country] => US
[patent_app_date] => 2011-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6106
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13078272
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/078272 | Method of treating mantle cell lymphoma | Mar 31, 2011 | Issued |